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Abstract
Amniotic membrane-derived mesenchymal cells (AMCs) are considered suitable candidates for a variety of cell-based
applications. In view of cell therapy application in uterine pathologies, we studied AMCs in comparison to cells isolated from
the endometrium of mares at diestrus (EDCs) being the endometrium during diestrus and early pregnancy similar from a
hormonal standpoint. In particular, we demonstrated that amnion tissue fragments (AM) shares the same transcriptional
profile with endometrial tissue fragments (ED), expressing genes involved in early pregnancy (AbdB-like Hoxa genes), pre-
implantantion conceptus development (Era, PR, PGRMC1 and mPR) and their regulators (Wnt7a, Wnt4a). Soon after the
isolation, only AMCs express Wnt4a and Wnt7a. Interestingly, the expression levels of prostaglandin-endoperoxide synthase
2 (PTGS2) were found greater in AM and AMCs than their endometrial counterparts thus confirming the role of AMCs as
mediators of inflammation. The expression of nuclear progesterone receptor (PR), membrane-bound intracellular
progesterone receptor component 1 (PGRMC1) and membrane-bound intracellular progesterone receptor (mPR), known
to lead to improved endometrial receptivity, was maintained in AMCs over 5 passages in vitro when the media was
supplemented with progesterone. To further explore the potential of AMCs in endometrial regeneration, their capacity to
support resident cell proliferation was assessed by co-culturing them with EDCs in a transwell system or culturing in the
presence of AMC-conditioned medium (AMC-CM). A significant increase in EDC proliferation rate exhibited the crucial role
of soluble factors as mediators of stem cells action. The present investigation revealed that AMCs, as well as their derived
conditioned media, have the potential to improve endometrial cell replenishment when low proliferation is associated to
pregnancy failure. These findings make AMCs suitable candidates for the treatment of endometrosis in mares.
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Introduction
Embryo-maternal communication is a pre-requisite for success-
ful implantation that facilitates the establishment, recognition, and
maintenance of pregnancy. Studies of early pregnancy in different
mammalian species have shown that the majority of embryo losses
occurs during the pre-implantation phase: in the horse, this phase
is very critical [1,2]. During this period, the conceptus (the embryo
and the associated extra-embryonic membranes) interacts with the
uterine environment via paracrine signaling to coordinate
attachment and implantation. Disruption of the integrity of the
endometrial tissue and of the capacity to support its functions are
the responsible factors in determining a subfertile phenotype [3].
As such, the development of chronic endometritis followed by
degenerative and abnormal changes of the endometrium, like
fibrosis (scarring) around the glands, might inhibit the regeneration
of traumatized endometrium. The damage then leads to an
impairment of the progenitor cell ratio that reduces the
endometrial tissue’s ability to regenerate and thus future foaling
rates as well. This mainly results in the inability of the tissue to
support embryo implantation.
Given the potential role of these cells have in remodeling the
endometrium, it may be reasonable to suggest cell therapies based
on mesenchymal stem cells (MSCs) as suitable strategies to restore
and maintain normal function in damaged reproductive tissues.
With this in mind, we recently retrieved MSCs from extra-fetal
tissues in the equine species [4]. For the first time, we compared
the proliferative and differentiative potential of amniotic mem-
brane-derived MSCs (AMCs) with bone marrow derived MSCs
(BM-MSCs). together with their possible application in the
treatment of horse tendon injuries [5,6]. We next demonstrated
the potential immunomodulatory properties of AMCs and their
conditioned medium (AMC-CM) in vitro, and proved the efficacy
of AMC-CM in the treatment of spontaneous horse tendon and
ligament injuries in vivo [7]. Data obtained in this study
demonstrated the crucial role of soluble factors in inhibiting
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peripheral blood mononucleated cell proliferation in vitro and in
improving healing in vivo. Taken together, the AMCs features
described so far by our group suggest this cell type as the most
suitable for regenerative medicine approaches [5] and its derived
conditioned media (CM) as a novel, cell-free therapeutic product
in regenerative medicine.
For these reasons, the aim of the present study was to better
understand the nature of AMCs, so that we may exploit their
potential role in uterine replacement therapy. AMCs were further
characterized for the expression of early pregnancy-associated
genes in view of their potential application in endometrial
regeneration or in stimulating the proper preparation of the
endometrium for embryo implantation.
The AbdB-like Hoxa gene (Hoxa9) and the wingless type genes
(Wnt7a, Wnt4a), which influence pre-implantantion conceptus
development, the classical oestrogen (ERa and ERb) and
progesterone (PR) receptors, and the more recently characterized
membrane-bound intracellular progesterone receptors (PGRMC1
and mPR), were evaluated on amniotic membrane fragment (AM)
or AMCs (at different passages) in comparison to endometrial
tissue fragments (ED) or isolated endometrial cells (EDCs) at
diestrus. We also looked at the expression of other genes, including
the cyclooxygenase prostaglandin E2 synthase (PTGS2), forkhead
box 01 (FOXO1), serum/glucocorticoid regulated kinase 1
(SGK1), and tumor protein p53 inducible protein3 (TP53) whose
transcriptional activity has been associated with luteo-protective
action [8], protection of the feto-maternal unit against oxidative
damage [9], improved reproductive outcome [10], and epithelial
ion transport and cell survival responses [11] during early
pregnancy, respectively. Since the endometrial stromal and
epithelial cells proliferation and differentiation through the period
of embryo preimplantation are controlled by ovarian steroid
hormones (progesterone and estrogen) [12,13], we aimed to
recreate the endometrial environment, thus culturing AMCs for
different passages in the presence of progesterone.
We further hypothesized that AMCs might induce tissue-
resident endometrial cells to proliferate or, alternatively, to
modulate the local immune response and promote endometrial
regeneration. MSCs, in general, are believed to play their role as
mediators of tissue repair through the release of paracrine factors
[14]. To test this hypothesis EDCs were cultured either with
AMCs in a transwell system or with their conditioned media, in
order to evaluate the capability of AMCs to increase the
proliferative potential of endometrial cells.
Materials and Methods
Materials
Samples were collected from horses slaughtered in a national
slaughterhouse (Titbit Srl, Bagnolo in Piano, Reggio Emilia, Italy)
with legal regulations.
Chemicals were obtained from Sigma-Aldrich Chemical (Milan,
Italy) unless otherwise specified, and tissue culture plastic dishes
were purchased from Euroclone (Milan, Italy).
Tissue collection and isolation
Three amniotic membranes were obtained at term of normal
pregnancies after vaginal delivery from three mares. Clean
collected portions of allanto-amnion were kept at 4uC in PBS
with 100 U/ml penicillin, 100 mg/ml streptomycin and 4 mg/ml
amphotericin B and were processed within 8 h. The amniotic
membrane was stripped from the overlying allantois and cut into
small pieces (about 9 cm2 each) before starting the enzymatic
digestion. Endometrial tissues were collected from 3 different
horses aged between 8 and 10 years, after euthanasia unrelated to
our experiments. Endometrial samples were obtained during the
reproductive season from normal-cycling mares at diestrus (early-
mid luteal phase). Before euthanasia, 5 ml of blood were collected
in heparinized tubes from all mares. After centrifugation, plasma
was separated, kept refrigerated and immediately transported to
the laboratory for progesterone determination by a quantitative
Enzyme Linked Fluorescent Assay (ELFA) based on the MiniVidas
(Biomerieux, Firenze, Italy) technology. According to the manu-
facturer, the measurement range of the assay varied from 0.25 to
80 ng/ml with an intra-assay variability of 4.12% and an inter-
assay variability of 6.32%.
Only uteri belonging to mares with an obvious corpus luteum
on the ovary and progesterone levels between 6 to 20 ng/ml,
indicative of the early/mid diestral phase of the estrous cycle [15],
were used for endometrial fragment collection and ensuing cell
culture.
Tissue fragments for RNA isolation were immediately immersed
in RNA Later solution, whereas those destined for cell isolation
and expansion procedure were kept at 4uC in saline solution
supplemented with 4 mg/ml amphotericin B, 100 IU/ml penicillin
and 100 mg/ml streptomycin and were processed within 8 h.
Cell isolation
Amniotic membrane-derived mesenchymal cells were isolated
as previously reported [4]. Briefly, amnion fragments were
incubated for 9 min at 38.5uC in PBS containing 2.4 U/mL
dispase (Becton Dickinson, Milan, Italy). After a resting period (5–
10 min) at room temperature in high-glucose Dulbecco’s modified
Eagle’s medium (HG-DMEM; EuroClone, Milan, Italy), supple-
mented with 10% heat inactivated fetal bovine serum (FBS) and
2 mM L-glutamine, the fragments were digested with 0.93 mg/
mL collagenase type I and 20 mg/mL DNAse (Roche, Mann-
heim, Germany) for approximately 3 h at 37uC. The amnion
fragments were then removed, and mobilized cells were passed
through a 100 mm cell strainer before being collected by
centrifugation at 2006g for 10 min.
Endometrial cells from diestrus mare’s uteri were obtained
according to the protocol described by Donofrio et al. [16] and
slightly modified for equine cells. Briefly, the endometrium was
digested in sterile filtered Hank’s buffered salt solution supple-
mented with 2 mg/ml collagenase II, 4 mg/ml bovine serum
albumine, and 0.4 mg/ml DNase I for 90 minutes at 38.5uC in a
shaking bath. Cells were then filtered through a membrane with a
pore size of 80 mm, centrifuged at 2006g for 10 minutes, and then
washed twice in PBS. This protocol allowed for the isolation of the
endometrial stromal portion.
Fibroblasts (used as a control for AMCs) were isolated from skin
specimens collected from three horses after euthanasia unrelated
to our experiments. Samples (2 mm3) were taken by excision and
fragments of approximately 1 mm were incubated with 40 mg/ml
collagenase IV for 3 h at 38.5uC. After digestion, cells were
washed and allowed to grow to confluence in 60-mm culture
dishes.
Before seeding, the primary cultures (P0) obtained from the
amnion, endometrium and skin were counted using a Burker
chamber with the trypan blue dye exclusion assay.
Cell expansion
Endometrial and fibroblast cells cultures were established in
HG-DMEM supplemented with 10% FBS, penicillin (100 UI/
ml)-streptomycin (100 mg/ml), 0.25 mg/ml amphotericin B and
2 mM L-glutamine. Medium was supplemented with 10 ng/ml
epidermal growth factor (EGF) for AMC cultures.
Amnion-Derived Cells and Andometrial Regeneration
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To remove non-adherent cells, the medium was replaced for the
first time after 72 h, and then changed either twice per week
thereafter or according to the experiment requirements. For
maintenance of cultures, cells were plated in flasks of 25 cm2 at the
density of 16105 cells/cm2 and incubated at 38.5uC in a
humidified atmosphere with 5% CO2. Adherent cells were
detached with 0.05% trypsin-EDTA just prior to reaching
confluence (80%) and then reseeded for culture maintenance at
the density of 16104 cells/cm2.
Molecular characterization of EDCs was performed only at P0
as de facto control for gene expression, whereas AMCs were
studied from P0 to P5.
Preparation of conditioned medium
AMCs and fibroblasts, at P3, were plated in 24-well plates at a
density of 16105 cells/well in DMEM standard complete medium.
To obtain AMC-CM and fibroblast-CM, cells were cultured for 5
days at 38.5uC in a humidified atmosphere with 5% CO2.
Supernatants from each plate were then collected, pooled,
centrifuged at 7006g, filtered (0.2 mm), and stored at 280uC.
This procedure was performed for cells obtained from three
different placentas and from three different samples of skin.
The collected supernatants were lyophilized and stored at 4uC
until use, at which point they were dissolved in sterile cell culture
water to one-quarter of the initial volume.
Molecular characterization
Total RNA was extracted from tissues (AM and ED) and cells
(AMCs and EDCs) immediately after isolation (P0) using TRI
ReagentH Solution (Life Technologies, Monza, Italy). Total RNA
was also extracted from AMCs at different passages (P1, P3 and
P5) and after culture in the presence of progesterone. Samples
were then treated with DNase in order to avoid DNA
contamination. RNA concentration and purity were measured
by Nanodrop Spectrophotometer (NanodropH ND1000). The
cDNA was synthesized from total RNA (500 ng) using a Taqman
Reverse Transcription reagents kit (Applied Biosystems, Branch-
burg, NJ). The gene expression evaluation was performed using
specific sequences; equine-specific oligonucleotide primers were
designed using open source PerlPrimer software v. 1.1.17, based
on available NCBI Equus caballus sequences or on mammal
multi-aligned sequences. Primers were designed across an exon–
exon junction in order to avoid genomic DNA amplification and
their sequence conditions and the references used are shown in
Table 1. Equine glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was employed as a reference gene in each sample in
order to standardize the results by eliminating variation in mRNA
and cDNA quantity and quality.
Conventional RT-PCR was performed in a 25 ml final volume
with RBC Taq DNA Polymerase (RBC Bioscience) under the
following conditions: initial denaturation at 95uC for 2 minutes, 32
cycles at 95uC for 30 seconds (denaturation), 55–60uC for 30
seconds (annealing), 72uC for 1 minute (elongation) and final
elongation at 72uC for 7 minutes. For conventional PCR, primers
were used at 300 nM final concentrations.
Quantitative PCRs were performed with SYBR green method
in a MyiQ iCycler thermal cycler (Biorad). Triplicate PCR
reactions were carried out for each sample analyzed. The reactions
were set on a strip in a final volume of 25 ml by mixing, for each
sample, 1 ml of cDNA, 12.5 ml of 2X concentrated Power
SybrHGreen PCR Master Mix (Applied Biosystems) containing
SYBR Green as a fluorescent intercalating agent, 0.2 mm forward
primer, 0.2 mm of reverse primer and MQ water. PCR efficiencies
were tested and found to be close to 1. The thermal profile for all
reactions was 10 minutes at 95uC and then 40 cycles of 15 seconds
at 95uC, 1 minute at 60uC. Fluorescence monitoring occurred at
the end of each cycle. Additional dissociation curve analysis was
per- formed and in all cases showed one single peak. The data thus
obtained were analyzed using the iQ5 optical system software
version 2.0 (BioRad). Gene expression levels found in AM and
AMCs were normalized and represented with respect to ED and
EDCs, respectively.
Proliferation studies
Growth curves. To obtain growth curves at P1 and P5,
AMCs and EDCs were plated at the density of 96103 cells into
six-well tissue culture plates. Every three days, over the 15 days of
culture, cells from one well of each plate were detached and
counted.
Doubling time (DT). Cell proliferation was determined as
previously reported [4]. DT for passages 1–5 was assessed plating
96103 cells into six-well tissue culture plates. Every 4 days cells
were trypsinized, counted and reseeded at the same density. Mean
DT was calculated from day 0 to day 4. The DT value was
obtained for each passage according to the formula DT = CT/
CD, where CT represents the culture time and CD = log(Nc/No)/
log2 represents the number of cell generations (Nc represents the
number of cells at confluence, No represents the number of seeded
cells). Data representative of three independent experiments are
reported.
EDC proliferation in presence of AMCs or AMC-CM. To
assess the potential of AMCs to increase EDCs proliferation
(evaluated as growth curves and DT) 24-well plates with 0.4 mm-
pore transwell inserts were used to physically separate the two cell
populations. EDCs were plated at 16104 cells/well in standard
complete medium and AMCs were added at the same density on
top of the inserts.
To evaluate the effect of AMC-CM on EDCs proliferation,
growth and DT were studied plating 96103 cells into six-well
tissue culture plates. For this experiment, cultures were established
in standard complete medium supplemented with 10% AMC-CM.
As a control group, EDCs were studied in the presence of either
fibroblasts separated with a transwell system or fibroblast-derived
CM.
AMCs culture in the presence of progesterone
To determine whether AMCs would be effective in replacement
therapy we cultured them in the presence of progesterone.
Cultures at P1 were established in HG-DMEM supplemented
with 10% FBS, 10 ng/ml EGF, 1% penicillin (100 UI/ml)/
streptomycin (100 mg/ml), 0.25 mg/ml amphotericin B, 2 mM L-
glutamine (standard complete medium) and 20 ng/ml of proges-
terone. For maintenance of the cultures, cells were plated at 16104
cells/cm2 and incubated at 38.5uC in a humidified atmosphere
with 5% CO2. Just prior to reaching confluence (80%), adherent
cells were detached with 0.05% trypsin-EDTA and then reseeded
for culture maintenance at the density of 16104 cells/cm2. The
medium was changed twice per week. Cells at P5 were the last
time point included for the molecular characterization studies.
Statistical analysis
For proliferation data, statistical analysis was performed using
GraphPad Instat Software version 3.00 for Windows (La Jolla, CA,
US). Three replicates for each experiment were performed.
Results are reported as mean 6 standard deviation (SD). One-
way analysis of variance (ANOVA) for multiple comparisons by
Student-Newman-Keuls multiple comparison tests was used.
Differences were considered statistically significant for P values
Amnion-Derived Cells and Andometrial Regeneration
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,0.05. For quantitative PCR data, non-parametric tests were
used. The Kruskal-Wallis test was used for comparison between
multiple groups whereas Mann-Whitney U-test was employed to
compare two groups. P,0.05 was considered significant.
Results
Cells isolation and expansion
Cells were selected purely on their ability to adhere to plastic.
For AMCs, initial viability was .90%, whereas for EDCs it was
.80%. All cell lines displayed the typical fibroblast-like morphol-
ogy (Figs 1A and 1B). AMCs observed at the early stages of culture
organised as tridimensional clusters (Fig 1C).
Molecular characterization
As previously reported, molecular studies demonstrated that at
P3 AMCs display a typical mesenchymal stromal phenotype,
expressing pluripotent and MSC-specific markers [4]. For further
information, see Supplementary Information. When the expres-
sion of genes associated to pre-implantantion conceptus develop-
ment was investigated, conventional RT-PCR analysis demon-
Table 1. Oligonucleotide sequences used for RT-PCR analysis.
REF SEQ Markers Forward (59R39) Reverse (59R39) TAnnealing bp
XM_001498494.3 Progesteron Receptor (PR) GTCAGTGGACAGATGCTGTA CGCCTTGATGAGCTCTCTAA 55uC 255
NM_001081772.1 Estrogen receptor a (ERa) TCCATGATCAGGTCCACCTTCT GGTGTCTGTCATCTTGTCCA 55uC 341
XM_001915519.2 Estrogen receptor b (ERb) TCAGCCTGTTCGACCAAGTG CCTTGAAGTCGTTGCCAGGA 60uC 194
NM_001256979.1 Membrane-associated progesterone receptor (MPR) GCCAAGTATCGTTACCGGAG AAGAGGATCTGGAGCGTGTG 55uC 173
XM_001914705.2 Membrane-associated progesterone receptor (PGRMC1) TCAACGGCAAGGTGTTCGAC GGCTCTTCCTCATCTGAGTA 58uC 280
XM_003364827.1 Homeobox protein Hox-A9-like (Hoxa9) ACGCTGGAACTGGAGAAAGA CTTTCGCTCGGTCCTTATTG 55uC 160
NM_001163856.1 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) AGATCAAGAAGGTGGTGAAG TTGTCATACCAGGAAATGAGC 59uC 178
XM_001501510.2 Wingless-type MMTV integration site family, member 4
(Wnt7a)
TTTCGGATTCCCGCAGTCTC CATCTGCACCTGCCTCTGAA 55uC 177
XM_001489623.2 Wingless-type MMTV integration site family, member
7A(Wnt7a)
CATGGTCTACCTCCGGATCG TATGACGATGATGGCGTCGG 55uC 134
XM_005600181.1 Tumor protein p53 inducible protein3 (TP53) TCGCATTTCAAGCCAAACCG CTTCCTTCTCCTTCCCGTCG 60uC 110
XM_005601179.1 Forkhead box 01 (FOX01) ATTGAGCGCTTGGACTGTG CGTTGTCTTGACACTGTGC 60uC 126
XM_005609749.1 Prostaglandin-endoperoxide synthase 2 (PTGS2) GATCCTAAGCGAGGTCCAGC AGGCGCAGTTTATGCTGTCT 60uC 101
XM_001504377 Serum/glucocorticoid regulated kinase 1 (SGK1) CTGCACTCCCTGAACATCGT ATGTTCTCCTTGCAGAGCCC 60uC 107
doi:10.1371/journal.pone.0111324.t001
Figure 1. Cell morphology. Monolayer of AMCs (A) and EDCs (B); tridimensional cluster of AMCs (C). Magnification, x 20; scale bar
= 20 mm.
doi:10.1371/journal.pone.0111324.g001
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strated that PR, mPR, PGRMC1, Hoxa9, Wnt7a, Wnt4a, as well
as PTGS2, FOXO1, SGK1 and TP53 were expressed in ED and
AM. While ERa was expressed by AM and ED, ERß was not
detected in both tissues.
Quantitative RT-PCR showed a statistically significant increase
in the expression of mPR (4.0860.37; P,0.01), PGRCM1
(1.5260.3; P,0.05), Wnt7a (105.41613.27), Wnt4a (1.6660.11;
P,0.05), and PTGS2 (1.5560.23; P,0.05) in the comparison of
AM to ED (Fig 2A). Although ERa expression was demonstrated
by conventional RT-PCR, when quantitatively analyzed it was
found to be statistically lower when comparing AM to ED.
At P0, right after cell isolation, AMCs expressed all the genes
studied with only the exception of ERa and ERß. When cells from
the amniotic membrane and endometrial tissue were quantita-
tively compared, data showed a significant upregulation in the
expression of PR (1.360.11; P,0.05), PGRCM1 (260.07; P,
0.01), Hoxa9 (1.7460.17; P,0.05), Wnt7a (3.1660.7; P,0.01),
and PTGS2 (5.6660.015) in AMCs (Fig 2B).
Despite being qualitatively detected in ED and AM and in cells
derived from both sources, the levels of FOXO1, SGK1 and TP53
found in AM and AMCs were significantly lower in comparison to
those observed in ED and EDCs (Fig 2B). No expression for the
genes of interest was detected in further passages with only the
exception of Hoxa9 whose mRNA was found at P1 (data not
shown). AMCs cultured in the presence of supplemented
progesterone, expressed Hoxa-9, PGRMC1 and mPR until the
last passage studied (Fig 3).
Proliferation studies
Growth curve and DT. At P1, EDCs and AMCs demon-
strated a growth curve with an initial lag phase of 3 days that
decreased at P5 with AMCs growing more rapidly than EDCs
during this phase (Figs 4A and 4B). The proliferative potential of
EDCs was higher at P1 than at P5 in contrast with the results of
AMCs.
The DT values at P1 were similar between the two cell lines
(Fig 4C). In EDCs, it significantly increased (P,0.05) toward P5.
On the contrary, the greater proliferative ability associated to
AMCs was found between P3 and P5, and was further confirmed
by the growth curve at passage 5. At each passage, the differences
observed between the DT values observed for AMCs and EDCs
was statistically significant (P,0.05). The mean DT value for the
EDCs was 2.1960.65 days, while it was 0.8860.22 days for
AMCs.
EDCs proliferation in presence of AMCs or AMC-
CM. In vitro studies demonstrated that co-culture with AMCs
significantly increased EDCs proliferation in all passages studied
(Figs 4 A, B, C). The mean DT value for EDCs in the transwell
experiment (1.78 days) had a decrease of ,1.23-fold in
comparison to baseline EDCs proliferation in standard complete
medium (2.19 days; P,0.05 for all comparisons). The culture in
the presence of AMC-CM was able to stimulate EDCs prolifer-
ation to the same level of that obtained when cells were grown in
the transwell system (DT value of 1.63 days with a decrease of
,1.34-fold). Co-culture with fibroblasts, physically separated
through a transwell system or in presence of their CM, did not
induce any change in the proliferative potential of EDCs (Figs 4 D,
E, F).
Discussion
As in humans, equine fetal adnexa have been recently suggested
as appealing candidates for the derivation of MSCs to be used in
cell-based therapies [4,17–26] due to their higher proliferation
capacity, longer telomeres, broader differentiation, and extensive
proliferative potential in comparison to cells obtained from adult
tissues [5,17,27].
We previously isolated AMCs from the equine amniotic
membranes confirming that these cells share specific characteris-
tics with embryonic and adult stem cells; they express represen-
tative mesenchymal (CD105, CD44, CD29, CD166) and plurip-
otent (Tra-1-60, SSEA-4, Oct-4) markers, are highly proliferative
and retain high plasticity [4,5]. We also provided evidence of their
superior efficacy in tendon regeneration compared to their bone
marrow counterparts when allogeneically transplanted in vivo
[4,6].
Taken together, these characteristics make AMCs suitable
candidates for endometrial regeneration. To test this hypothesis
we further characterized AMCs comparing them to uterine
stromal cells collected at diestrus, due to the similarities found in
the hormonal profile between early pregnancy and the diestrous
stage. Both stages are characterized by high blood progesterone
level [28].
Our data demonstrates that at P0, AM and AMCs are similar to
ED and EDCs, respectively, for the expression of some endome-
trial-specific genes. Although our study only assayed a few genes,
we selected the ones that are crucial in the process of conceptus-
endometrium interaction. In particular, we found the expression of
Wnt4a statistically higher in AM than ED and with similar results
between AMCs and EDCs. This data can be explained with the
role that the wingless type genes play in reproductive events:
Figure 2. Molecular characterization of endometrial tissue (ED) and amnion (AM) (A), and endometrial cells at diestrus stage (EDCs)
and amniotic-derived stem cells (AMCs) (B). Qualitative and quantitative RT–PCR analysis for the expression of genes associated to
differentiation of uterine stromal cells during early pregnancy (Hoxa9), those influencing pre-implantantion conceptus development (ERa, ERb, PR,
PGRMC1 and mPR) and their regulators (Wnt7a,Wnt4a), and prostaglandin E2 synthase (PTGS2), FOXO1, SGK1, and TP53. GAPDH was used as reference
gene.
doi:10.1371/journal.pone.0111324.g002
Figure 3. Molecular characterization of AMCs. Conventional
RT-PCR analysis of evaluated genes in AMCs after culture with
progesterone from passage 1 (P1) to passage (P5).
doi:10.1371/journal.pone.0111324.g003
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including the establishment and maintenance of pregnancy,
implantation, proliferation, and secretion activity of endometrium
during the estrous cycle and pregnancy [29–32].
According to this, we can hypothesize that in horses Wnt7a and
Wnt4a regulation allows the synchronization of the uterus and
embryo development during the pre-implantation period of the
mare as proposed in sheep and mice [28,33,34].
The AbdB-like Hoxa family includes a second class of genes
differentially expressed during early pregnancy and primarily
confined to the mesenchymal cell compartment during in utero
Figure 4. Proliferation studies. Growth curve at P1 (A) and P5 (B) for AMCs and EDCs alone or in co-culture with AMCs by transwell
system or by AMC-conditioned medium (AMC-CM). Doubling times at different passages during cell culture for both AMCs and EDCs (C) in
different culture conditions. Asterisks represent statistically different doubling times with respect to P1 (P,0.01). Growth curve at P1 (D) and P5 (E) for
EDCs alone or in co-culture with fibroblast by transwell system or by fibroblast-conditioned medium. Doubling times at different passages during cell
culture for EDCs (E) in different culture conditions with fibroblast. Asterisks represent statistically different doubling times with respect to P1 (P,0.01).
doi:10.1371/journal.pone.0111324.g004
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development [35,36]. Among these genes, AMCs and EDCs share
the expression of Hoxa-9, which is specifically involved in the
Mu¨llerian duct cell patterning into oviducts, uterus, and vagina
[35], as well as uterine function during early pregnancy [36,37]. In
particular, this gene is considered as one of the primary steroid
hormone-responsive genes in the uterine stroma of humans and
mice [35]. Its expression is regulated by factors such as ovarian
steroids, interferons, and embryonic oestrogen in human [38],
mouse [31], sheep [39], pig [40], and recently in equine
endometrium [28]. As in humans, equine proliferation and
secretion of endometrial cells, implantation of embryo, renewal
of endometrial layers, and configuration of endometrial gland
morphogenesis [29,33,41] are essential processes for the establish-
ment of pregnancy [42] controlled by ovarian steroid hormones
and local growth factors [43]. Among these, progesterone and
estrogens are at the forefront of the cascade that could play a
critical role in endometrial maturation and receptivity [44] and are
thought to influence pre-implantation conceptus development
[45,46]. These hormones are thought to act indirectly via the
endometrium. As mentioned above, progesterone mediates
endometrial maturity and receptivity through specific nuclear
receptors [47]. Data obtained herein demonstrate that the levels of
expression of mPR and PGRMC1 detected in AM and AMCs
respectively, are even higher than those found in ED and EDCs.
These findings may indicate the differential biological effect
exerted by progesterone on the amniotic membrane and on the
cells derived from it. While in ED it acts through a relatively slow
‘genomic pathway’ [45,46], in the amniotic tissues progesterone
seems to work via ligand-specific steroid receptors, including the
non-classical membrane-associated receptors we analysed
(PGRMC1 and mPR) [48,49].
The co-expression of Wnt and Hoxa9 as well as the
progesterone receptors in AMCs, suggests that these cells share
similar cellular and molecular characteristics with uterine stromal
cells. For some of the genes studied, our results confirm those
obtained in humans, showing the same pattern of expression [50].
The loss of expression of some markers observed soon after AMCs
isolation, as well as in EDCs, could depend on the culture
conditions employed in this study with the consequent changes
induced during the expansion.
When the expression of FOXO1, SGK1, and TP53 was
investigated the levels found in AM and AMCs were significantly
lower than those observed in ED and EDCs. So far, no data has
been published regarding these markers as crucial players in the
process of conceptus-endometrium interaction in the equine
species, and only one paper reports the link between TP53
transcriptional activity and cattle reproduction (10). Further
studies are required to elucidate the role of FOXO1, SGK1, and
TP53 regulation in horses. At a molecular level, this study
reinforces our previous findings regarding the immunomodulatory
potential of the amniotic membrane and the cells derived from
them (7) and further highlights their potential use in cell-based
therapies. This observation comes from the higher levels of
PTGS2 expression found in AM and AMCs compared to their
endometrial counterparts. It is important to point out that
prostaglandin E2 not only exerts a crucial role as immunosup-
pressive molecules during pro-inflammatory events, but are also
known to be actively involved at the onset of pregnancy as
temporary luteo-protective factors [51].
To recreate the biochemical cues found during gestation,
characterized by high progesterone levels, we optimized the AMCs
culture system supplementing the media with progesterone. The
presence of progesterone in the culture media was sufficient to
preserve the expression of membrane-bound intracellular proges-
terone receptors and Hoxa-9 along the 5 passages in vitro. Since
endometrial receptivity depends on the number of progesterone
receptors in epithelial and stromal cells [52], our data provide an
intriguing indication of the possible application of AMCs in
endometrial regeneration.
Whether the major contribution of AMCs to the healing process
depends on their ability to differentiate, the immunomodulatory
and trophic factors they release, or is a combination of the two
mechanisms is still under debate [53,54]. The present study also
provides evidence of the role that soluble signals produced by
AMCs may have in promoting EDC proliferation. Indeed, the
presence of AMCs by transwell system or the effect of AMC-CM
increased the EDCs proliferation.
In conclusions, the present work lays the foundation for in vivo
studies on the potential application of AMCs in the treatment of
horse uterine diseases. A substantial overlap was found between
equine amnion and endometrium based on gene expression
profiling, indicating that AMCs are ideal therapeutic candidates
for uterine cells replenishment when scarcity or low proliferation
of uterine endometrial cells is associated with pregnancy failure.
Besides this, our data reinforce the idea that MSCs obtained from
gestational tissues exert their beneficial effects in tissue regener-
ation through the release of soluble factors and indicates the
conditioned media as novel therapeutic cell-free products for
regenerative medicine applications.
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